-
An Updated Perspective on the Use of EEG for Diagnosis, Prediction, and Treatment Individualization in Depression
Prof. Giorgio di LorenzoDone
-
🥗
Done
-
Neuroplastic effects of EEG neurofeedback
Dr. Tomas RosDone
-
📣
Done
-
Non-Invasive Remote EEG Monitoring at Home in Epilepsy: Insights from the EEG@HOME Study
Dr. Andrea BiondiDone
-
Contribution of new methods for combined EEG/MEG source analysis and optimized mc-TES to focal medication-resistant epilepsy
Prof. Dr. Carsten WoltersDone
-
☕
Done
-
☕
Done
-
🎤👥💬
Done
-
🥗
Done
CEO and Founder Katrina Wendel-Mitoraj, PhD, has a background in semiconductor manufacturing at Samsung and MEMC. Her nuanced understanding of electrode sensitivity distributions from her PhD and post-doctoral research helps drive the company's innovative technical, design, and vision. Her expertise serves as the cornerstone for SOENIA®'s groundbreaking solutions in epilepsy monitoring and therapeutic treatment. She is the inventor of the 13 granted patents for SOENIA®'s subdermal electrode technology.
Â
SOENIA® is a company that addresses challenges faced by refractory epilepsy patients. The SOENIA® UltimateEEGâ„¢ Subscalp Electrode aims for continuous, high-precision monitoring and therapeutic neuromodulation, providing a comprehensive approach to epilepsy management. The innovative proprietary electrodes are a breakthrough in multichannel recording and stimulation with the aim to treat refractory epilepsy under local anesthesia with a small incision.Â
SOENIA® will collaborate with eemagine in two ways to address the monitoring and therapeutic needs of refractory epilepsy patients. Firstly, the collaboration aims to measure subscalp EEG as a temporary recording as an intermediate monitoring device to record seizures. The longer-term aim is to help neurologists identify patients suitable for therapeutic implants such as difficult-to-detect seizures that would benefit from temporary recording in the patient's natural environment instead of an EEG laboratory.
Secondly, SOENIA® will investigate neuromodulation patterns suitable for subdermal stimulation from the external eemagine RIO device targeting focal refractory epilepsy. These patterns will be developed for the SOENIA® UltimateEEGâ„¢ Subdermal Electrode to accommodate the RIO RX300’s three stimulation channels plus three recording channels. The long-term goal is to identify a neurostimulation strategy that benefits patients.Â
By combining these two approaches, we will be able to address a substantial unmet need for an advanced, patient-friendly solution that offers continuous monitoring and effective therapeutic intervention for refractory epilepsy.